REQUEST A DEMO
Total
USD $0.00
Search more companies

Corefarmaceutica S.A.S. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Corefarmaceutica S.A.S. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Corefarmaceutica S.A.S. is based in Ecuador, with the head office in Cuenca. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on September 07, 2021. There are currently 2 (2023) people employed by Corefarmaceutica S.A.S.. The company’s latest financial report indicates a net sales revenue drop of 69.9% in 2023. Its total assets decreased by 57.1% over the same period.

Headquarters
Miguel Cordero 2-30
Cuenca; Azuay;

Contact Details: Purchase the Corefarmaceutica S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Corefarmaceutica S.A.S. report to view the information.
Outstanding Shares:
Purchase the Corefarmaceutica S.A.S. report to view the information.
Registered Capital:
Purchase the Corefarmaceutica S.A.S. report to view the information.
Incorporation Date:
September 07, 2021
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Corefarmaceutica S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-69.9%
Total operating revenue
-69.9%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-57.1%
Total equity
-1.38%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?